CSA Medical announced today that study data support the use of its RejuvenAir system for treating chronic bronchitis.
Boston-based CSA Medical designed its metered cryospray (MCS) treatment using the RejuvenAir System. RejuvenAir, a proprietary interventional liquid nitrogen spray cryotherapy system, utilize software-driven dosimetry and specialty catheter.
Get the full story at our sister site, Drug Delivery Business News.